International journal of molecular sciences

Fixing Faulty CFTR Protein in Human Nasal Airway Cells Using CFTR Drugs and mRNA Delivery

Updated

Abstract

Chitosan-mediated CFTR mRNA delivery successfully restored CFTR function in airway cultures from cystic fibrosis patients with rare variants.

  • CFTR modulators improved channel function in most cystic fibrosis patient cultures, but not in those with class I or rare variants.
  • Electrophysiological measurements confirmed CFTR function restoration following chitosan-mediated mRNA delivery in patients with rare variants.
  • Immunofluorescence staining showed increased CFTR protein expression and restored epithelial barrier integrity after treatment.
  • MUC5AC expression, associated with mucus viscosity, was significantly reduced after successful intervention, nearing levels found in healthy controls.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors declare that there were no conflicts of interest and the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free